Cargando…
Metal based donepezil analogues designed to inhibit human acetylcholinesterase for Alzheimer’s disease
Among neurodegenerative disorders, Alzheimer’s disease (AD) is one of the most common disorders showing slow progressive cognitive decline. Targeting acetylcholinesterase (AChE) is one of the major strategies for AD therapeutics, as cholinergic pathways in the cerebral cortex and basal forebrain are...
Autores principales: | Junaid, Md., Islam, Nazrul, Hossain, Md. Kamal, Ullah, M. Obayed, Halim, Mohammad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382135/ https://www.ncbi.nlm.nih.gov/pubmed/30785927 http://dx.doi.org/10.1371/journal.pone.0211935 |
Ejemplares similares
-
The in silico and in vitro analysis of donepezil derivatives for Anopheles acetylcholinesterase inhibition
por: Rants’o, Thankhoe A., et al.
Publicado: (2022) -
Kinetic and structural studies on the interactions of Torpedo californica acetylcholinesterase with two donepezil-like rigid analogues
por: Caliandro, Rosanna, et al.
Publicado: (2018) -
Effect of Donepezil, Tacrine, Galantamine and Rivastigmine on Acetylcholinesterase Inhibition in Dugesia tigrina
por: Bezerra da Silva, Cristiane, et al.
Publicado: (2016) -
MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy
por: Shamsi, Anas, et al.
Publicado: (2020) -
Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer’s Disease Therapy
por: Arya, Ashwani, et al.
Publicado: (2021)